| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 55 | 2025 | 2562 | 3.070 |
Why?
|
| Radiography, Abdominal | 4 | 2024 | 63 | 1.150 |
Why?
|
| Earthquakes | 2 | 2023 | 13 | 0.980 |
Why?
|
| Emergencies | 3 | 2024 | 120 | 0.840 |
Why?
|
| Radiology Information Systems | 1 | 2024 | 78 | 0.800 |
Why?
|
| Rib Fractures | 1 | 2023 | 8 | 0.790 |
Why?
|
| Ribs | 1 | 2023 | 48 | 0.780 |
Why?
|
| Disasters | 1 | 2023 | 25 | 0.780 |
Why?
|
| Contrast Media | 10 | 2019 | 986 | 0.740 |
Why?
|
| Breast Carcinoma In Situ | 1 | 2022 | 3 | 0.730 |
Why?
|
| Chylous Ascites | 2 | 2011 | 9 | 0.640 |
Why?
|
| Gastrointestinal Hemorrhage | 2 | 2017 | 239 | 0.640 |
Why?
|
| Cerebral Angiography | 7 | 2015 | 213 | 0.630 |
Why?
|
| Infarction, Middle Cerebral Artery | 3 | 2015 | 54 | 0.590 |
Why?
|
| Embolism, Air | 2 | 2017 | 21 | 0.580 |
Why?
|
| Diagnostic Imaging | 3 | 2015 | 448 | 0.560 |
Why?
|
| Diagnosis, Differential | 16 | 2016 | 1519 | 0.550 |
Why?
|
| Middle Cerebral Artery | 2 | 2015 | 22 | 0.540 |
Why?
|
| Necrosis | 2 | 2023 | 203 | 0.540 |
Why?
|
| Thrombolytic Therapy | 4 | 2015 | 253 | 0.530 |
Why?
|
| Humans | 81 | 2025 | 93132 | 0.520 |
Why?
|
| Thrombosis | 3 | 2017 | 308 | 0.520 |
Why?
|
| Cerebrum | 1 | 2017 | 14 | 0.510 |
Why?
|
| Splenic Artery | 1 | 2017 | 10 | 0.510 |
Why?
|
| Pancreatitis | 1 | 2017 | 94 | 0.510 |
Why?
|
| Thoracic Vertebrae | 3 | 2017 | 88 | 0.490 |
Why?
|
| Stroke | 5 | 2022 | 1073 | 0.480 |
Why?
|
| Intestinal Diseases | 1 | 2017 | 84 | 0.480 |
Why?
|
| Liver Diseases | 4 | 2017 | 243 | 0.450 |
Why?
|
| Stents | 3 | 2007 | 406 | 0.450 |
Why?
|
| Middle Aged | 38 | 2025 | 27535 | 0.440 |
Why?
|
| Female | 49 | 2025 | 48542 | 0.430 |
Why?
|
| Brain Ischemia | 5 | 2022 | 407 | 0.420 |
Why?
|
| Aged | 29 | 2025 | 20395 | 0.420 |
Why?
|
| Drainage | 3 | 2011 | 170 | 0.410 |
Why?
|
| Retroperitoneal Space | 2 | 2017 | 41 | 0.400 |
Why?
|
| Abdomen | 2 | 2017 | 118 | 0.400 |
Why?
|
| Male | 47 | 2025 | 44355 | 0.400 |
Why?
|
| Thoracic Cavity | 1 | 2013 | 2 | 0.390 |
Why?
|
| Intracranial Embolism | 3 | 2017 | 29 | 0.390 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 2 | 2011 | 9 | 0.390 |
Why?
|
| Myositis | 1 | 2013 | 18 | 0.390 |
Why?
|
| Meglumine | 2 | 2011 | 36 | 0.380 |
Why?
|
| Aspergillosis | 1 | 2013 | 39 | 0.380 |
Why?
|
| Lipomatosis | 1 | 2012 | 9 | 0.380 |
Why?
|
| Hepatolenticular Degeneration | 3 | 2007 | 18 | 0.360 |
Why?
|
| Abdominal Pain | 6 | 2017 | 143 | 0.360 |
Why?
|
| Organometallic Compounds | 2 | 2011 | 138 | 0.350 |
Why?
|
| Carotid Artery Diseases | 2 | 2015 | 100 | 0.350 |
Why?
|
| Carcinoma | 3 | 2011 | 439 | 0.350 |
Why?
|
| Hematoma | 2 | 2011 | 105 | 0.340 |
Why?
|
| Foreign Bodies | 2 | 2013 | 61 | 0.340 |
Why?
|
| Adult | 31 | 2025 | 27849 | 0.340 |
Why?
|
| Lung | 4 | 2021 | 1359 | 0.340 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2011 | 83 | 0.330 |
Why?
|
| Aged, 80 and over | 14 | 2025 | 7039 | 0.330 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 4 | 2011 | 297 | 0.330 |
Why?
|
| Nuclear Medicine | 1 | 2010 | 12 | 0.320 |
Why?
|
| Liver | 4 | 2017 | 1206 | 0.320 |
Why?
|
| Cholecystitis, Acute | 2 | 2010 | 9 | 0.320 |
Why?
|
| Neck Injuries | 1 | 2010 | 14 | 0.320 |
Why?
|
| Mesenteric Vascular Occlusion | 2 | 2009 | 20 | 0.310 |
Why?
|
| Craniocerebral Trauma | 1 | 2010 | 52 | 0.310 |
Why?
|
| Sensitivity and Specificity | 8 | 2021 | 1909 | 0.300 |
Why?
|
| Publishing | 1 | 2010 | 91 | 0.300 |
Why?
|
| Reproducibility of Results | 6 | 2023 | 2705 | 0.290 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2010 | 112 | 0.290 |
Why?
|
| Breast Neoplasms | 2 | 2022 | 3155 | 0.280 |
Why?
|
| Periodicals as Topic | 1 | 2010 | 166 | 0.280 |
Why?
|
| Urologic Diseases | 1 | 2008 | 38 | 0.270 |
Why?
|
| Head Injuries, Closed | 1 | 2007 | 11 | 0.260 |
Why?
|
| Observer Variation | 3 | 2023 | 570 | 0.260 |
Why?
|
| Appendicitis | 2 | 2019 | 64 | 0.260 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2007 | 7 | 0.260 |
Why?
|
| Embolization, Therapeutic | 3 | 2010 | 272 | 0.260 |
Why?
|
| Arteries | 1 | 2008 | 170 | 0.260 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2007 | 15 | 0.260 |
Why?
|
| Ileal Diseases | 1 | 2007 | 24 | 0.260 |
Why?
|
| Abdominal Injuries | 1 | 2007 | 47 | 0.260 |
Why?
|
| Thoracic Injuries | 1 | 2007 | 41 | 0.260 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2007 | 107 | 0.250 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2020 | 626 | 0.250 |
Why?
|
| Adolescent | 15 | 2021 | 9550 | 0.240 |
Why?
|
| Fibrinolytic Agents | 3 | 2015 | 238 | 0.240 |
Why?
|
| Hemorrhage | 1 | 2008 | 289 | 0.240 |
Why?
|
| Hodgkin Disease | 1 | 2007 | 144 | 0.240 |
Why?
|
| Gallbladder | 3 | 2011 | 32 | 0.240 |
Why?
|
| Retrospective Studies | 16 | 2025 | 10128 | 0.240 |
Why?
|
| Pulmonary Embolism | 2 | 2020 | 226 | 0.240 |
Why?
|
| Ultrasonography | 7 | 2013 | 679 | 0.240 |
Why?
|
| Ureteral Diseases | 1 | 2005 | 11 | 0.230 |
Why?
|
| Scrotum | 1 | 2005 | 14 | 0.230 |
Why?
|
| Carotid Artery, Internal | 3 | 2015 | 69 | 0.230 |
Why?
|
| Abdomen, Acute | 1 | 2025 | 21 | 0.230 |
Why?
|
| Liver Neoplasms | 1 | 2011 | 773 | 0.230 |
Why?
|
| Angioplasty, Balloon | 1 | 2006 | 90 | 0.230 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 1910 | 0.220 |
Why?
|
| Emergency Service, Hospital | 4 | 2025 | 576 | 0.220 |
Why?
|
| Young Adult | 11 | 2025 | 6922 | 0.220 |
Why?
|
| Lumbar Vertebrae | 2 | 2009 | 355 | 0.220 |
Why?
|
| Child | 13 | 2019 | 7273 | 0.220 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2007 | 235 | 0.220 |
Why?
|
| Ureter | 1 | 2005 | 80 | 0.220 |
Why?
|
| Hernia, Inguinal | 1 | 2005 | 75 | 0.210 |
Why?
|
| Portal Vein | 3 | 2017 | 119 | 0.210 |
Why?
|
| Radiography | 7 | 2013 | 750 | 0.210 |
Why?
|
| Sturge-Weber Syndrome | 1 | 2004 | 9 | 0.210 |
Why?
|
| Acute Disease | 5 | 2019 | 838 | 0.210 |
Why?
|
| Arachnoid Cysts | 1 | 2004 | 4 | 0.210 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2004 | 19 | 0.210 |
Why?
|
| Cerebral Hemorrhage | 3 | 2011 | 362 | 0.200 |
Why?
|
| Crush Syndrome | 1 | 2023 | 1 | 0.200 |
Why?
|
| Hypertension, Pulmonary | 1 | 2007 | 368 | 0.200 |
Why?
|
| Meningioma | 1 | 2004 | 62 | 0.200 |
Why?
|
| Meningeal Neoplasms | 1 | 2004 | 69 | 0.200 |
Why?
|
| Splenic Infarction | 1 | 2002 | 2 | 0.190 |
Why?
|
| Salmonella enterica | 1 | 2002 | 8 | 0.190 |
Why?
|
| Radiologists | 1 | 2023 | 55 | 0.190 |
Why?
|
| Salmonella Infections | 1 | 2002 | 18 | 0.190 |
Why?
|
| Brain Diseases | 1 | 2004 | 172 | 0.190 |
Why?
|
| Calcinosis | 1 | 2004 | 219 | 0.190 |
Why?
|
| Tertiary Care Centers | 1 | 2023 | 127 | 0.190 |
Why?
|
| Prospective Studies | 4 | 2024 | 4546 | 0.190 |
Why?
|
| Triage | 1 | 2023 | 131 | 0.180 |
Why?
|
| Patient Admission | 2 | 2013 | 118 | 0.180 |
Why?
|
| Predictive Value of Tests | 6 | 2017 | 1703 | 0.180 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 2 | 2021 | 458 | 0.170 |
Why?
|
| Angiography | 3 | 2015 | 192 | 0.170 |
Why?
|
| Deglutition Disorders | 1 | 2022 | 124 | 0.160 |
Why?
|
| Pneumonia | 1 | 2022 | 192 | 0.160 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2015 | 180 | 0.160 |
Why?
|
| Kidney | 2 | 2020 | 1093 | 0.160 |
Why?
|
| Thorax | 1 | 2020 | 77 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 569 | 0.160 |
Why?
|
| Risk Factors | 8 | 2022 | 5900 | 0.150 |
Why?
|
| Area Under Curve | 2 | 2017 | 336 | 0.150 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2019 | 18 | 0.150 |
Why?
|
| Computed Tomography Angiography | 2 | 2020 | 162 | 0.150 |
Why?
|
| Software | 1 | 2023 | 669 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 3 | 2017 | 833 | 0.150 |
Why?
|
| Sternum | 1 | 2019 | 35 | 0.140 |
Why?
|
| Urinary Calculi | 2 | 2009 | 45 | 0.140 |
Why?
|
| Venous Thromboembolism | 1 | 2020 | 168 | 0.140 |
Why?
|
| Child, Preschool | 6 | 2019 | 3781 | 0.130 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 393 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2010 | 606 | 0.130 |
Why?
|
| Fasciitis | 1 | 2017 | 13 | 0.130 |
Why?
|
| Coronary Angiography | 2 | 2009 | 232 | 0.130 |
Why?
|
| Osteogenesis | 1 | 2019 | 273 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 147 | 0.120 |
Why?
|
| Klebsiella Infections | 1 | 2017 | 32 | 0.120 |
Why?
|
| Kyphosis | 1 | 2016 | 24 | 0.120 |
Why?
|
| Dyspnea | 1 | 2017 | 86 | 0.120 |
Why?
|
| Scoliosis | 1 | 2016 | 40 | 0.120 |
Why?
|
| Pancreas | 1 | 2017 | 256 | 0.120 |
Why?
|
| Carotid Stenosis | 2 | 2009 | 113 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 338 | 0.110 |
Why?
|
| Disease Progression | 2 | 2017 | 1529 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 333 | 0.110 |
Why?
|
| Rheumatic Diseases | 1 | 2015 | 30 | 0.110 |
Why?
|
| Vascular Calcification | 1 | 2015 | 47 | 0.100 |
Why?
|
| Radiation Dosage | 3 | 2020 | 224 | 0.100 |
Why?
|
| Colitis | 1 | 2017 | 260 | 0.100 |
Why?
|
| Syndrome | 2 | 2012 | 432 | 0.100 |
Why?
|
| Fiber Optic Technology | 1 | 2013 | 32 | 0.100 |
Why?
|
| Invasive Pulmonary Aspergillosis | 1 | 2013 | 8 | 0.100 |
Why?
|
| Meninges | 1 | 2013 | 13 | 0.100 |
Why?
|
| Collateral Circulation | 1 | 2013 | 36 | 0.100 |
Why?
|
| Deglutition | 1 | 2013 | 85 | 0.100 |
Why?
|
| Chi-Square Distribution | 4 | 2017 | 354 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2018 | 753 | 0.090 |
Why?
|
| Prognosis | 3 | 2015 | 3890 | 0.090 |
Why?
|
| Antifungal Agents | 1 | 2013 | 122 | 0.090 |
Why?
|
| Treatment Outcome | 6 | 2017 | 9070 | 0.090 |
Why?
|
| Adrenalectomy | 1 | 2011 | 41 | 0.090 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2009 | 101 | 0.090 |
Why?
|
| Glasgow Coma Scale | 2 | 2011 | 72 | 0.090 |
Why?
|
| Cerebrovascular Circulation | 1 | 2013 | 229 | 0.090 |
Why?
|
| Papilloma | 1 | 2011 | 23 | 0.080 |
Why?
|
| Evaluation Studies as Topic | 2 | 2021 | 241 | 0.080 |
Why?
|
| Bile Ducts | 1 | 2011 | 61 | 0.080 |
Why?
|
| Biliary Tract Neoplasms | 1 | 2011 | 36 | 0.080 |
Why?
|
| Biliary Tract Diseases | 1 | 2011 | 36 | 0.080 |
Why?
|
| Turkey | 1 | 2010 | 22 | 0.080 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2010 | 1 | 0.080 |
Why?
|
| Bronchial Arteries | 1 | 2010 | 6 | 0.080 |
Why?
|
| Echinococcosis | 1 | 2010 | 5 | 0.080 |
Why?
|
| Resuscitation Orders | 1 | 2011 | 64 | 0.080 |
Why?
|
| Hemoptysis | 1 | 2010 | 25 | 0.080 |
Why?
|
| Choledocholithiasis | 1 | 2010 | 14 | 0.080 |
Why?
|
| Water Intoxication | 1 | 2010 | 3 | 0.080 |
Why?
|
| Gallstones | 1 | 2010 | 21 | 0.080 |
Why?
|
| Science | 1 | 2010 | 36 | 0.080 |
Why?
|
| Bile | 1 | 2010 | 60 | 0.080 |
Why?
|
| Whole Body Imaging | 1 | 2010 | 40 | 0.080 |
Why?
|
| Flank Pain | 2 | 2009 | 4 | 0.080 |
Why?
|
| Carcinoma, Papillary | 1 | 2011 | 159 | 0.080 |
Why?
|
| Image Enhancement | 2 | 2009 | 498 | 0.080 |
Why?
|
| Internal Fixators | 1 | 2009 | 29 | 0.080 |
Why?
|
| Pelvis | 1 | 2010 | 99 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2011 | 177 | 0.080 |
Why?
|
| Pelvic Bones | 1 | 2009 | 44 | 0.070 |
Why?
|
| Intestine, Small | 1 | 2011 | 311 | 0.070 |
Why?
|
| Iohexol | 1 | 2009 | 20 | 0.070 |
Why?
|
| Echinococcosis, Hepatic | 1 | 2009 | 3 | 0.070 |
Why?
|
| Jejunal Diseases | 1 | 2009 | 9 | 0.070 |
Why?
|
| Dysmenorrhea | 1 | 2010 | 58 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2012 | 3450 | 0.070 |
Why?
|
| Fracture Fixation, Internal | 1 | 2009 | 89 | 0.070 |
Why?
|
| Hypertension | 2 | 2011 | 748 | 0.070 |
Why?
|
| Mesentery | 1 | 2008 | 46 | 0.070 |
Why?
|
| Aging | 1 | 2013 | 725 | 0.070 |
Why?
|
| Laparotomy | 1 | 2008 | 63 | 0.070 |
Why?
|
| Hemothorax | 1 | 2008 | 11 | 0.070 |
Why?
|
| Cystitis | 1 | 2008 | 12 | 0.070 |
Why?
|
| Pneumocephalus | 1 | 2008 | 12 | 0.070 |
Why?
|
| Osteoradionecrosis | 1 | 2008 | 18 | 0.070 |
Why?
|
| Myocardial Bridging | 1 | 2007 | 5 | 0.070 |
Why?
|
| Iopamidol | 1 | 2007 | 9 | 0.070 |
Why?
|
| Ileum | 1 | 2008 | 167 | 0.070 |
Why?
|
| Aortic Rupture | 1 | 2008 | 52 | 0.070 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2008 | 46 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2011 | 887 | 0.070 |
Why?
|
| Trauma Severity Indices | 1 | 2007 | 46 | 0.070 |
Why?
|
| Jejunum | 1 | 2007 | 76 | 0.070 |
Why?
|
| Anisotropy | 1 | 2007 | 61 | 0.070 |
Why?
|
| Temperature | 1 | 2009 | 421 | 0.070 |
Why?
|
| Aneurysm | 1 | 2007 | 57 | 0.060 |
Why?
|
| Hypersensitivity | 1 | 2009 | 161 | 0.060 |
Why?
|
| Cysts | 1 | 2008 | 99 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 300 | 0.060 |
Why?
|
| Microscopy, Electron | 1 | 2007 | 429 | 0.060 |
Why?
|
| Algorithms | 2 | 2017 | 1948 | 0.060 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2008 | 97 | 0.060 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2008 | 154 | 0.060 |
Why?
|
| Peritoneal Neoplasms | 1 | 2008 | 183 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2022 | 2434 | 0.060 |
Why?
|
| Ischemia | 1 | 2008 | 252 | 0.060 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2008 | 142 | 0.060 |
Why?
|
| Mesenteric Artery, Inferior | 1 | 2006 | 3 | 0.060 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2006 | 18 | 0.060 |
Why?
|
| Ureteroscopy | 1 | 2005 | 34 | 0.060 |
Why?
|
| Pregnancy Outcome | 1 | 2007 | 267 | 0.060 |
Why?
|
| Hematuria | 1 | 2005 | 49 | 0.060 |
Why?
|
| Rare Diseases | 1 | 2005 | 71 | 0.060 |
Why?
|
| Multivariate Analysis | 3 | 2013 | 984 | 0.060 |
Why?
|
| Follow-Up Studies | 5 | 2012 | 3814 | 0.060 |
Why?
|
| Renal Dialysis | 1 | 2008 | 349 | 0.060 |
Why?
|
| Venous Insufficiency | 1 | 2004 | 11 | 0.050 |
Why?
|
| Iliac Vein | 1 | 2004 | 32 | 0.050 |
Why?
|
| Stainless Steel | 1 | 2004 | 4 | 0.050 |
Why?
|
| Brain | 2 | 2012 | 2337 | 0.050 |
Why?
|
| Mandibular Condyle | 1 | 2004 | 8 | 0.050 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2004 | 31 | 0.050 |
Why?
|
| Polytetrafluoroethylene | 1 | 2004 | 72 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2008 | 376 | 0.050 |
Why?
|
| Logistic Models | 3 | 2013 | 1240 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 106 | 0.050 |
Why?
|
| Length of Stay | 1 | 2007 | 820 | 0.050 |
Why?
|
| Nausea | 2 | 2017 | 93 | 0.050 |
Why?
|
| Hypovolemia | 1 | 2023 | 3 | 0.050 |
Why?
|
| Vomiting | 2 | 2017 | 108 | 0.050 |
Why?
|
| Infant | 3 | 2017 | 3156 | 0.050 |
Why?
|
| O Antigens | 1 | 2002 | 12 | 0.050 |
Why?
|
| Ciprofloxacin | 1 | 2002 | 23 | 0.050 |
Why?
|
| Anti-Infective Agents | 1 | 2002 | 85 | 0.040 |
Why?
|
| Age Factors | 2 | 2019 | 1898 | 0.040 |
Why?
|
| Time | 1 | 2021 | 80 | 0.040 |
Why?
|
| Kidney Pelvis | 1 | 2002 | 45 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2017 | 1849 | 0.040 |
Why?
|
| Ureteral Obstruction | 1 | 2002 | 60 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2008 | 1447 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 2017 | 2427 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 31 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2013 | 709 | 0.040 |
Why?
|
| Radionuclide Imaging | 1 | 2020 | 180 | 0.040 |
Why?
|
| Pregnancy | 1 | 2007 | 3128 | 0.040 |
Why?
|
| Radiation Exposure | 1 | 2019 | 25 | 0.040 |
Why?
|
| Perfusion | 1 | 2020 | 260 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2019 | 1269 | 0.030 |
Why?
|
| Radiography, Interventional | 2 | 2010 | 149 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 283 | 0.030 |
Why?
|
| Fecal Impaction | 1 | 2017 | 4 | 0.030 |
Why?
|
| Hepatic Veins | 1 | 2017 | 25 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 2543 | 0.030 |
Why?
|
| Reference Standards | 1 | 2017 | 145 | 0.030 |
Why?
|
| Body Size | 1 | 2017 | 98 | 0.030 |
Why?
|
| Appendix | 1 | 2017 | 30 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 2 | 2009 | 448 | 0.030 |
Why?
|
| Artifacts | 1 | 2018 | 241 | 0.030 |
Why?
|
| Hepatic Artery | 1 | 2017 | 82 | 0.030 |
Why?
|
| Pressure | 1 | 2017 | 165 | 0.030 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2017 | 106 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 207 | 0.030 |
Why?
|
| Neoplasms | 1 | 2011 | 3168 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2017 | 108 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1102 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 1786 | 0.030 |
Why?
|
| Child Development | 1 | 2016 | 166 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 873 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 451 | 0.030 |
Why?
|
| Time Factors | 2 | 2013 | 5380 | 0.020 |
Why?
|
| Colon | 1 | 2017 | 540 | 0.020 |
Why?
|
| Alberta | 1 | 2012 | 9 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2013 | 170 | 0.020 |
Why?
|
| Leukoaraiosis | 1 | 2011 | 3 | 0.020 |
Why?
|
| Intracranial Hemorrhage, Hypertensive | 1 | 2011 | 5 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2013 | 340 | 0.020 |
Why?
|
| Abdominal Neoplasms | 1 | 2011 | 38 | 0.020 |
Why?
|
| Pelvic Neoplasms | 1 | 2011 | 42 | 0.020 |
Why?
|
| Cystic Duct | 1 | 2011 | 5 | 0.020 |
Why?
|
| Hepatic Duct, Common | 1 | 2011 | 10 | 0.020 |
Why?
|
| Thoracic Neoplasms | 1 | 2011 | 64 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 774 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2011 | 66 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 33 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 76 | 0.020 |
Why?
|
| Cholecystography | 1 | 2010 | 6 | 0.020 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2010 | 11 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2010 | 74 | 0.020 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2011 | 92 | 0.020 |
Why?
|
| Linear Models | 1 | 2011 | 413 | 0.020 |
Why?
|
| Iatrogenic Disease | 1 | 2010 | 69 | 0.020 |
Why?
|
| Mesenteric Arteries | 1 | 2009 | 29 | 0.020 |
Why?
|
| Mesenteric Veins | 1 | 2009 | 36 | 0.020 |
Why?
|
| Dissection | 1 | 2009 | 44 | 0.020 |
Why?
|
| Autopsy | 1 | 2009 | 126 | 0.020 |
Why?
|
| Cadaver | 1 | 2009 | 195 | 0.020 |
Why?
|
| Tomography, Spiral Computed | 1 | 2009 | 75 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1925 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2009 | 42 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2009 | 212 | 0.020 |
Why?
|
| Embolism | 1 | 2009 | 32 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 456 | 0.020 |
Why?
|
| Enteritis | 1 | 2008 | 23 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2009 | 400 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 453 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2008 | 174 | 0.020 |
Why?
|
| Age Distribution | 1 | 2008 | 206 | 0.020 |
Why?
|
| Ultrasonography, Doppler | 1 | 2008 | 76 | 0.020 |
Why?
|
| Catheterization, Peripheral | 1 | 2008 | 59 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 981 | 0.020 |
Why?
|
| Ureteral Calculi | 1 | 2006 | 9 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2009 | 258 | 0.020 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2004 | 1 | 0.010 |
Why?
|
| Phlebography | 1 | 2004 | 69 | 0.010 |
Why?
|
| Facial Pain | 1 | 2004 | 11 | 0.010 |
Why?
|
| Temporomandibular Joint Disorders | 1 | 2004 | 21 | 0.010 |
Why?
|
| Vascular Patency | 1 | 2004 | 118 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2008 | 430 | 0.010 |
Why?
|
| Survival Rate | 1 | 2008 | 1945 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 1697 | 0.010 |
Why?
|
| Kidney Calculi | 1 | 2006 | 343 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2004 | 293 | 0.010 |
Why?
|
| Registries | 1 | 2008 | 995 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 2009 | 0.010 |
Why?
|
| Hydronephrosis | 1 | 2002 | 22 | 0.010 |
Why?
|
| Ultrasonography, Interventional | 1 | 2002 | 121 | 0.010 |
Why?
|
| Rotation | 1 | 2002 | 90 | 0.010 |
Why?
|